Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Procter & Gamble Health Ltd

PGHL.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Small Cap Analyst: BUY

Last Close

$62.15

▲ +0.14%

Market Cap $1.03B · Vol 20.40K

Key Metrics

P/E Ratio

30.42

FWD: 23.90

Market Cap

$1.03B

Small Cap

Div Yield

2.61%

Semi-annual dividend

EPS Growth

+21.50%

YoY

RSI (14)

18.63

Momentum

Beta

0.30

vs Market

52W High

$73.08

18.04% below

52W Low

$49.32

22.88% above

Volume

20.40K

Avg 21.73K

P/B

15.19

Price-to-book

ROE

N/A

Return on equity

Free Float

47.81%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Procter & Gamble Health Ltd (PGHL.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does PGHL.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-3.46%

-14.26%

+12.76%

+18.90%

YTD

+4.97%

-4.90%

+1.57%

+13.98%

Financials & Valuation

TTM · Annual

Total Revenue	$150.65M
Net Income	$34.98M
Revenue Growth (YoY)	+7.37%
Gross Margin	65.54%
Operating Margin	30.89%
Net Profit Margin	23.22%
ROE	N/A
ROA · ROIC	55.01% · N/A

P/E Ratio	30.42
Forward P/E (FY1)	23.90
PEG Ratio	5.12
P/S	5.66
P/B	15.19
P/FCF	23.93
EPS Growth	+21.50%
Outstanding Shares	16.60M

Technical Indicators

50-Day SMA	$67.13
200-Day SMA	$59.17
RSI (14)	18.63
Beta	0.30
52-Week High	$73.08
52-Week Low	$49.32

Volume Today	20.40K
Avg Daily Volume (30D)	21.73K
Relative Volume	0.94x
Volatility (10D)	33.42
Volatility (30D)	30.66
Free Float	47.81%

Analyst Consensus

BUY

Current Price $62.15

Mean Target N/A

52W Low$49.32 52W High$73.08

Current

Target

$49.32 $73.08

Current Analyst target

· 2 analysts

Identifiers

ExchangeNSE India

FIGIBBG001S83700

ISININE199A01012

CountryIndia

Sub-IndustryGeneric Pharmaceuticals

Earnings DateNov 4, 2026

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

SUNPHARMA.NS Sun Pharmaceutical Industries Ltd -0.10% 4578.T Otsuka Holdings Co Ltd -3.26% CIPLA.NS Cipla Ltd -0.60% ZYDUSLIFE.NS Zydus Lifesciences Ltd -2.75% RICHTER.BU Richter Gedeon Vegyeszeti Gyar Nyrt +1.56%

Company Profile

Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.